Platform

Patent Portfolio

Senhwa’s patent portfolio is comprised of 135 issued patents and 52 pending patent applications. Intellectual property rights include patents covering product derivatives, pharmaceutical formulations, method of use, manufacturing process, crystalline forms and combination therapies.

Patents have been granted mainly in the US, Europe, Canada, Japan, South Korea, Mainland China, Australia, New Zealand and Taiwan.

• Taiwan

  1

• Russia

  2

• Israel

  2

• New Zealand

  2

• China

  3

• South Korea

  3

• Japan

  3

• Hong Kong

  3

• Canada

  4

• Australia

  4

• United States

  14

• Europe

  69